breastfeeding safe glp 1 GLP-1 While Breastfeeding: Safety & Clinical Guidance – PlexusDx GLP-1 Use While Breastfeeding: Safety

The difference is that GLP-1 users eat less because the drugs suppress their appetites, so the foods they do eat need to be packed with nutrients, Christen said

Tirzepatide drugs like Zepbound continue to cause severe injuries, like vision loss, pancreatitis, blood clots, and a range of serious gastrointestinal injuries, in some patients

Visit Found Health Today FAQs What medications does Found prescribe

In clinical trials of FDA-approved GLP-1 medications used under medical supervision, some patients achieved average losses consistent with 4 to 8 pounds per month over time, with a total weight loss of roughly 15% to 21% of body weight over the full treatment course

US retailers that move early to tailor product ranges and merchandise their shelves targeting GLP-1 users may be better positioned to protect share as eating behaviors change. GlobalData projects that the GLP-1 pill market will grow from $3.2 billion in 2025 to $34.3 billion in 2031, with an annual CAGR of 48.4% over the six-year period